AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glucobeat G 0.5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Saan Labs

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glucobeat G 0.5mg/500mg Tablet

Diabex Duo 0.5mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Diabex Duo is a component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabex Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and potential blood tests (blood cell counts, liver function) are recommended under your doctor's guidance.

Primary Ingredients of Glucobeat G 0.5mg/500mg Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Glucobeat G 0.5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glucobeat G 0.5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glucobeat G 0.5mg/500mg Tablets. Ingest the tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with a meal.

Common Side effects of Glucobeat G 0.5mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glucobeat G 0.5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glucobeat G 0.5mg/500mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with a meal.

How Glucobeat G 0.5mg/500mg Tablet works:

Glucobeat G tablets (0.5mg/500mg) combine glimepiride and metformin, two agents used to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glucobeat G 0.5mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glucobeat G 0.5mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Lactation and Glucobeat G 0.5mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glucobeat G 0.5mg/500mg tablets, as dosage modification may be necessary. Consult a physician before taking this medication. Glucobeat G 0.5mg/500mg tablets are contraindicated in individuals with severe kidney disease. Close monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glucobeat G 0.5mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. For those with mild to moderate liver disease, initiation should be at a low dose; however, its use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glucobeat G 0.5mg/500mg Tablet :

Should you forget a Glucobeat G 0.5mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glucobeat G 0.5mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glucobeat G 0.5mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glucobeat G 0.5mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention, including discontinuing Glucobeat G 0.5mg/500mg Tablets, if you experience these symptoms.
Glucobeat G 0.5mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glucobeat G 0.5mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glucobeat G 0.5mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Glucobeat G 0.5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glucobeat G 0.5mg/500mg tablets with alcohol is unsafe. Alcohol can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glucobeat G 0.5mg/500mg T...
74
MRP 86
13% off